-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Recently, WACKER reported a significant increase in sales of €2,132.
2 million, up 29 percent from a year earlier (€1,658.
6 million), with sales down 2 percent from the previous quarter due to lower demand, mainly due to higher product prices.
Earnings before interest, taxes, depreciation and amortization (EBITDA) amounted to EUR 457 million, still up 2 percent
year-on-year against the backdrop of surging energy and raw material prices.
Net cash flow decreased to EUR 296 million
due to higher working capital and higher capital expenditures.
WACKER's full-year EBITDA forecast is expected to be high at €2.
1 billion to €2.
3 billion, while the Group's sales forecast remains unchanged at €8.
0 billion to €8.
5 billion
.
WACKER posted sales growth in all regions in the third quarter, with the Americas recording the largest
increase.
Sales in the region, also supported by currency exchange, rose 46 percent to €346.
7 million
.
In Asia, WACKER generated sales of €965.
8 million, up 37 percent year-on-year.
Sales in Europe increased by 12 percent to EUR 714.
5 million
.
WACKER SILICONES generated sales of €889.
6 million in the third quarter, up 31 percent year-on-year.
Higher product prices and optimized product mix due to the increase in the proportion of lucrative specialty silicone products were the main reasons for the
increase in sales.
Sales increased significantly year-on-year in almost every application area, especially for silicone products for healthcare, wound care, and industrial and adhesives
.